Updated on 2026/07/23

写真a

 
YOSHIDA ATSUSHI
 
Organization
Graduate School of Medicine Department of Clinical Medical Science Lecturer
School of Medicine Department of Medical Science
Title
Lecturer
Affiliation
Institute of Medcine

Position

  • Graduate School of Medicine Department of Clinical Medical Science 

    Lecturer  2025.07 - Now

  • School of Medicine Department of Medical Science 

    Lecturer  2025.07 - Now

Degree

  • 博士(医学) ( Osaka City University )

Papers

  • Gallium-67 SPECT/CT Detection of Lower Extremity Muscle Abscess in Vibrio vulnificus Infection

    Kotani K.

    Clinical Nuclear Medicine   51 ( 8 )   e635 - e637   2026( ISSN:03639762

  • Ovarian Mucinous Borderline Tumor with Abnormal I-131 Uptake: A Case Report

    Kaneko Tetsuya, Yoshida Atsushi, Higashiyama Shigeaki, Michiwaki Yuito, Moriura Natsuko, Kawabe Joji, Miki Yukio

    Japanese Archive of cases conference of clinical nuclear medicine   7 ( 0 )   1 - 5   2025.03( eISSN:2434768X

     More details

    A patient, a female in her 70s, underwent total thyroidectomy for thyroid carcinoma and was referred to our hospital seven months later for Iodine-131 (I-131) therapy to ablate the remaining thyroid tissue. The patient received 2.55 GBq of I-131 and single photon emission computed tomography/computed tomography was performed on Day 11. This revealed irregular and heterogeneous abnormal uptake in the pelvis. Ultrasonography revealed no abnormalities in the uterus, but a multilocular mass measuring approximately 12 cm was found in the left ovary. Blood tests revealed an elevated carbohydrate antigen 19-9 level of 13.7 U/mL. The patient underwent simple abdominal total hysterectomy, bilateral adnexectomy, and partial omentectomy. Histopathological examination confirmed a diagnosis of ovarian mucinous borderline tumor. No thyroid tissue was detected.

    DOI: 10.32291/nmj.7.0_1

    CiNii Research

  • Ovarian Mucinous Borderline Tumor with Abnormal I-131 Uptake: A Case Report(タイトル和訳中)

    Kaneko Tetsuya, Yoshida Atsushi, Higashiyama Shigeaki, Michiwaki Yuito, Moriura Natsuko, Kawabe Joji, Miki Yukio

    Japanese Archive of Cases Conference of Clinical Nuclear Medicine   7   1 - 5   2025.03

     More details

    症例は70歳代女性で、甲状腺癌(ステージcT4N0M0)のため甲状腺全摘術を受け、病理組織学的に右葉の乳頭癌(pT1、pEx0、R1)と左葉の乳頭癌(pT3b、pEx0、R1)の二つの悪性腫瘍が認められた。7ヵ月後に残存甲状腺組織へのアブレーション目的でI-131療法を行った。I-131(2.55GBq)を投与し、投与11日目にSPECT/CTを行った。その結果、骨盤内で不整・不均一な異常集積が検出された。超音波では子宮に異常はみられなかったが、左卵巣に約12cm大の多房性腫瘤を認めた。血清腫瘍マーカーはCA19-9が13.7U/mLと上昇していたため、単純腹式子宮全摘術、両側付属器切除術、大網部分切除術を施行した。病理組織学的診断は卵巣粘液性境界悪性腫瘍であった。

  • Can you see this? Shrimp head foreign body Reviewed

    Atsushi Yoshida, Taro Shimono, Yukio Miki

    Japanese Journal of Radiology   43 ( 7 )   1226 - 1227   2025( ISSN:18671071

     More details

    Publishing type:Research paper (scientific journal)   Kind of work:Joint Work   International / domestic magazine:International journal  

    DOI: 10.1007/s11604-025-01739-z

    PubMed

  • Diagnostic accuracy of vision-language models on Japanese diagnostic radiology, nuclear medicine, and interventional radiology specialty board examinations(タイトル和訳中)

    Oura Tatsushi, Tatekawa Hiroyuki, Horiuchi Daisuke, Matsushita Shu, Takita Hirotaka, Atsukawa Natsuko, Mitsuyama Yasuhito, Yoshida Atsushi, Murai Kazuki, Tanaka Rikako, Shimono Taro, Yamamoto Akira, Miki Yukio, Ueda Daiju

    Japanese Journal of Radiology   42 ( 12 )   1392 - 1398   2024.12( ISSN:1867-1071

     More details

    2019~2023年までの日本の放射線診断学(JDR)、核医学(JNM)およびインターベンショナルラジオロジー(JIR)認定試験の問題に関し、視覚言語モデル(VLM)による画像読影の診断精度や正答率を調査した。GPT-4+GPT-4V、GPT-4o、Claude-3 SonnetおよびClaude-3 Opusを用い正答率をMcNemar検定で比較した。その結果、GPT-4oはJDR、JNMやJIR試験で全体的に最も高い正答率で、Claude-3 Opusと続いた。また、全種類の問題ではGPT-4oはJIR試験のClaude-3 Opusを除き他のVLMよりも優れ、画像を含む問題ではGPT-4oはJNM試験のClaude-3 Opusを除き、JDRおよびJNM試験で他のVLMに比べ優れていた。以上より、GPT-4oはJDR、JNMおよびJIR専門委員会試験の全種類の問題や画像を含む問題に対し、最も高い正答率を示すことが確認された。

  • Diagnostic accuracy of vision-language models on Japanese diagnostic radiology, nuclear medicine, and interventional radiology specialty board examinations.

    Tatsushi Oura, Hiroyuki Tatekawa, Daisuke Horiuchi, Shu Matsushita, Hirotaka Takita, Natsuko Atsukawa, Yasuhito Mitsuyama, Atsushi Yoshida, Kazuki Murai, Rikako Tanaka, Taro Shimono, Akira Yamamoto, Yukio Miki, Daiju Ueda

    Japanese journal of radiology   42 ( 12 )   1392 - 1398   2024.12( ISSN:18671071

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:Domestic journal  

    PURPOSE: The performance of vision-language models (VLMs) with image interpretation capabilities, such as GPT-4 omni (GPT-4o), GPT-4 vision (GPT-4V), and Claude-3, has not been compared and remains unexplored in specialized radiological fields, including nuclear medicine and interventional radiology. This study aimed to evaluate and compare the diagnostic accuracy of various VLMs, including GPT-4 + GPT-4V, GPT-4o, Claude-3 Sonnet, and Claude-3 Opus, using Japanese diagnostic radiology, nuclear medicine, and interventional radiology (JDR, JNM, and JIR, respectively) board certification tests. MATERIALS AND METHODS: In total, 383 questions from the JDR test (358 images), 300 from the JNM test (92 images), and 322 from the JIR test (96 images) from 2019 to 2023 were consecutively collected. The accuracy rates of the GPT-4 + GPT-4V, GPT-4o, Claude-3 Sonnet, and Claude-3 Opus were calculated for all questions or questions with images. The accuracy rates of the VLMs were compared using McNemar's test. RESULTS: GPT-4o demonstrated the highest accuracy rates across all evaluations with the JDR (all questions, 49%; questions with images, 48%), JNM (all questions, 64%; questions with images, 59%), and JIR tests (all questions, 43%; questions with images, 34%), followed by Claude-3 Opus with the JDR (all questions, 40%; questions with images, 38%), JNM (all questions, 42%; questions with images, 43%), and JIR tests (all questions, 40%; questions with images, 30%). For all questions, McNemar's test showed that GPT-4o significantly outperformed the other VLMs (all P < 0.007), except for Claude-3 Opus in the JIR test. For questions with images, GPT-4o outperformed the other VLMs in the JDR and JNM tests (all P < 0.001), except Claude-3 Opus in the JNM test. CONCLUSION: The GPT-4o had the highest success rates for questions with images and all questions from the JDR, JNM, and JIR board certification tests.

    DOI: 10.1007/s11604-024-01633-0

    PubMed

  • Investigation of the effectiveness of no-reference metric in image evaluation in nuclear medicine

    Higashiyama S.

    Plos One   19 ( 11 )   e0310305   2024.11

  • 生体腎移植後の急性期腎機能低下の診断に二酸化炭素造影CTが有用であった1例

    淺野 数男, 中野 真理子, 塚本 和充, 岩井 友明, 壁井 和也, 吉田 敦史, 大植 智史, 酒井 峻介, 大谷 暢之, 寺山 英作, 松下 和樹, 原田 翔平, 尾崎 正典, 出口 亮, 村井 一超, 影山 健, 山本 晃, 東山 滋明, 河邉 讓治, 三木 幸雄

    脈管学   64 ( Suppl. )   S210 - S210   2024.10( ISSN:0387-1126

  • 放射性ヨード不応性甲状腺癌の孤立性肺転移に対し高周波アブレーションによる治療 チロシンキナーゼ阻害薬の導入を行わずFDG-PET/CTによる視覚的な再病期分類 2症例の報告(Radiofrequency Ablation for Radioiodine-Refractory Isolated Lung Metastasis from Thyroid Cancer: Visual Restaging by FDG-PET/CT without Tyrosine Kinase Inhibitor Introduction, A Report of Two Cases)

    Yamaguchi Taiki, Yoshida Atsushi, Tsujisaka Takumi, Sakai Shunsuke, Higashiyama Shigeaki, Kageyama Ken, Yamamoto Akira, Miki Yukio, Kawabe Joji

    Japanese Archive of Cases Conference of Clinical Nuclear Medicine   6   1 - 6   2024

     More details

    症例1は70代女性で、甲状腺乳頭癌の術後肺転移に対し放射性ヨウ素内用療法が施行されたが病変の増大が認められたため、放射性ヨード不応性甲状腺癌を疑い、FDG-PET/CTイメージングを施行した。症例2は60代男性で、甲状腺癌の術後に未分化癌と病理診断され肺転移も伴っていた。放射性ヨウ素内用療法が予定されFDG-PET/CTイメージングが施行され、FDGの異常集積が描出されたため放射性ヨード不応性甲状腺癌が疑われた。両例ともにFDG-PET/CTイメージングでは肺転移巣に強いFDG異常集積が描出され、放射性ヨード不応性が示唆されたため、高周波アブレーションによる治療が選択された。なお、治療後のCT検査では転移巣の退縮が観察され再発もみられなかったため、放射性ヨード不応性甲状腺癌に通常用いられるチロシンキナーゼ阻害薬(TKI)の投与は施行しなかった。本例から、甲状腺癌の肺転移に対する治療戦略の決定に、TKI開始前のFDG-PET/CT撮像による視覚的再病期分類の重要性が指摘された。

  • Abnormal distribution of I-131 due to numerous burying needles in the body

    Kawabe Joji, Yoshida Atsushi, Higashiyama Shigeaki

    Japanese Archive of cases conference of clinical nuclear medicine   6 ( 0 )   7 - 13   2024( eISSN:2434768X

     More details

    A man in his 70s who had undergone total thyroidectomy for thyroid cancer was admitted to our department for I-131 radioiodine remnant thyroid ablation and was administered 3.33 GBq of I-131, and a confirmatory scintigraphy was performed 10 days after administration. MIP images showed abnormal I-131 distribution scattered throughout the body, in addition to abnormal I-131 accumulation in the thyroid bed. SPECT/CT images showed that the abnormal distribution of I-131 was within the skin and muscles, and there were many small objects of high density corresponding to the abnormal accumulation. These objects were approximately 1 to 5 mm in size on the CT images. According to the patient, when he was in his 20s, he underwent needle-burying acupuncture to treat stiff shoulders and lower back pain, in which a 24-karat gold needle was inserted into the affected area, cut, and buried.

    DOI: 10.32291/nmj.6.0_7

    CiNii Research

  • Radiofrequency Ablation for Radioiodine-Refractory Isolated Lung Metastasis from Thyroid Cancer: Visual Restaging by FDG-PET/CT without Tyrosine Kinase Inhibitor Introduction, A Report of Two Cases

    Yamaguchi Taiki, Yoshida Atsushi, Tsujisaka Takumi, Sakai Shunsuke, Higashiyama Shigeaki, Kageyama Ken, Yamamoto Akira, Miki Yukio, Kawabe Joji

    Japanese Archive of cases conference of clinical nuclear medicine   6 ( 0 )   1 - 6   2024( eISSN:2434768X

     More details

    Fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) is valuable for visually staging recurrent thyroid cancer, particularly in patients with suspected radioactive iodine-refractory pulmonary metastasis from thyroid cancer. In Case 1, despite undergoing radioactive iodine therapy for pulmonary metastasis following papillary thyroid carcinoma surgery, an increase in the metastatic lesion was observed, prompting the suspicion of iodine refractivity. FDG-PET/CT imaging revealed strong abnormal FDG accumulation in the pulmonary metastases. In Case 2, a pulmonary metastasis from thyroid cancer was originally pathologically diagnosed as a poorly differentiated tumor, and FDG-PET/CT imaging was conducted due to suspected iodine refractivity. Both patients showed a single pulmonary metastasis site that was considered iodine-refractory. Radiofrequency ablation (RFA) for pulmonary metastases of thyroid cancer may delay the introduction of tyrosine kinase inhibitors (TKIs), which are commonly used for iodine-refractory thyroid cancer; however, their use is associated with side effects and high medical costs. RFA was performed in cases 1 and 2, and both patients progressed without recurrence; thus, TKIs were not administered. Visual staging using FDG-PET/CT before TKI initiation for pulmonary metastases from thyroid cancer is beneficial in determining treatment strategies.

    DOI: 10.32291/nmj.6.0_1

    CiNii Research

  • I-131の集積を認めた左卵巣粘液性境界悪性腫瘍の一例

    金子 哲也, 吉田 敦史, 東山 滋明, 河邉 讓治, 三木 幸雄

    核医学   61 ( 1 )   50 - 50   2024( ISSN:0022-7854

  • Ra-223治療の治療適応についてSPECT/CTが有用であった1例

    東山 滋明, 松江 泰佑, 大年 太陽, 加藤 実, 岩井 友明, 吉田 敦史, 大町 哲史, 内田 潤次, 河邉 讓治

    核医学   61 ( 1 )   49 - 50   2024( ISSN:0022-7854

  • Ra-223治療の治療適応についてSPECT/CTが有用であった1例

    東山 滋明, 松江 泰佑, 大年 太陽, 加藤 実, 岩井 友明, 吉田 敦史, 大町 哲史, 内田 潤次, 河邉 讓治

    核医学   61 ( Suppl. )   S169 - S169   2024( ISSN:0022-7854

  • I-131異常集積を認めた骨盤腔内巨大腫瘍の1例

    河邉 讓治, 吉田 敦史, 東山 滋明

    核医学   61 ( Suppl. )   S169 - S169   2024( ISSN:0022-7854

▼display all

MISC

Presentations

▼display all

Grant-in-Aid for Scientific Research

  • ディープラーニングによる神経内分泌腫瘍の核医学診断・治療効果予測

    Grant-in-Aid for Early-Career Scientists  2026

  • ディープラーニングによる神経内分泌腫瘍の核医学診断・治療効果予測

    Grant-in-Aid for Early-Career Scientists  2025

Charge of on-campus class subject

  • 核医学(核医学総論)

    2025   Intensive lecture   Graduate school

  • 核医学(核医学各論)

    2025   Intensive lecture   Graduate school

  • 核医学実習(核医学機能画像実習1)

    2025   Intensive lecture   Graduate school

  • 核医学実習(核医学機能画像実習2)

    2025   Intensive lecture   Graduate school